Derek N J Hart
Overview
Explore the profile of Derek N J Hart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prue R, Vari F, Radford K, Tong H, Hardy M, DRozario R, et al.
J Immunother
. 2015 Feb;
38(2):71-6.
PMID: 25658616
Preclinical studies have suggested that purified populations of CD1c (BDCA-1) blood-derived dendritic cells (BDC) loaded with tumor-specific peptides may be a feasible option for prostate cancer immunotherapy. We performed an...
12.
Gasiorowski R, Clark G, Bradstock K, Hart D
Br J Haematol
. 2013 Dec;
164(4):481-95.
PMID: 24321020
Novel therapies with increased efficacy and decreased toxicity are desperately needed for the treatment of acute myeloid leukaemia (AML). The anti CD33 immunoconjugate, gemtuzumab ozogamicin (GO), was withdrawn with concerns...
13.
Shahin K, Sartor M, Hart D, Bradstock K
Transplantation
. 2013 Aug;
96(8):753-62.
PMID: 23903010
Background: Dendritic cells (DC) are important in the development of acute graft-versus-host disease (GVHD) after allogeneic hemopoietic cell transplantation (alloHCT). The trafficking of immature DC from blood to GVHD target...
14.
Gasiorowski R, Ju X, Hart D, Clark G
Immunol Lett
. 2012 Oct;
149(1-2):93-100.
PMID: 23072861
Dendritic cells (DC) are a heterogeneous population of leucocytes which play a key role in initiating and modulating immune responses. The human CD300 family consists of six immunoregulatory leucocyte membrane...
15.
Kassianos A, Hardy M, Ju X, Vijayan D, Ding Y, Vulink A, et al.
Eur J Immunol
. 2012 Jun;
42(6):1512-22.
PMID: 22678905
Human blood myeloid DCs can be subdivided into CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) subsets that display unique gene expression profiles, suggesting specialized functions. CD1c(+) DCs express TLR4 while CD141(+) DCs...
16.
Freeman L, Lam A, Petcu E, Smith R, Salajegheh A, Diamond P, et al.
J Immunol
. 2011 Sep;
187(8):3987-96.
PMID: 21908738
The graft-versus-myeloma (GVM) effect represents a powerful form of immune attack exerted by alloreactive T cells against multiple myeloma cells, which leads to clinical responses in multiple myeloma transplant recipients....
17.
Fromm P, Gottlieb D, Bradstock K, Hart D
Pathology
. 2011 Sep;
43(6):605-15.
PMID: 21897329
The recent Food and Drug Administration (FDA) approval of a cellular therapy to treat castration resistant prostate cancer has reinforced the potential of cellular therapy to consolidate current pharmacological approaches...
18.
Wilkinson R, Woods K, DRozario R, Prue R, Vari F, Hardy M, et al.
Cancer Immunol Immunother
. 2011 Aug;
61(2):169-179.
PMID: 21874303
Immunotherapy is a promising new treatment for patients with advanced prostate and ovarian cancer, but its application is limited by the lack of suitable target antigens that are recognized by...
19.
Dean M, Flower R, Eisen D, Minchinton R, Hart D, Vuckovic S
Immunology
. 2010 Nov;
132(2):296-305.
PMID: 21091907
Mannose-binding lectin (MBL) is a serum lectin that plays a significant role in innate host defence. Individuals with mutations in exon 1 of the MBL2 gene have reduced MBL ligand...
20.
Ding Y, Ju X, Azlan M, Hart D, Clark G
Immunol Lett
. 2010 Oct;
134(2):161-6.
PMID: 20970455
Dendritic cells (DC) are a heterogeneous population of bone marrow derived leucocytes that are essential in the initiation of primary T lymphocyte responses. DC are identified as Lineage negative, HLA-DR(+)...